Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pomper

Showing results (331-340 of 525) with videos related to

Pageof 53
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2022
Hetero-bivalent agents targeting FAP and PSMASrikanth Boinapally, Alla Lisok, Gabriela Lofland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2023
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial CarcinomaXiaojiang Duan, Lei Xia, Zhuochen Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2000
Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studiesM G Pomper, J L Musachio, U Scheffel, et al.
European Journal of Radiology|September 3, 2013
Detection and localization of carcinoma within the prostate using high resolution transrectal gamma imaging (TRGI) of monoclonal antibody directed at prostate specific membrane antigen (PSMA)--proof of concept and initial imaging resultsBenjamin L Franc, Steve Y Cho, Seth A Rosenthal, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide TherapyJohannes von Hinten, Malte Kircher, Alexander Dierks, et al.
Cancers|February 15, 2022
Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [<sup>177</sup>Lu]Lu-PSMA I&TPhilipp E Hartrampf, Franz-Xaver Weinzierl, Sebastian E Serfling, et al.
Frontiers in Oncology|December 2, 2022
Automated lesion detection of breast cancer in [<sup>18</sup>F] FDG PET/CT using a novel AI-Based workflowJeffrey P Leal, Steven P Rowe, Vered Stearns, et al.
Journal of Medicinal Chemistry|December 5, 2008
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancerYing Chen, Catherine A Foss, Youngjoo Byun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancerBrian P Neuman, John B Eifler, Mark Castanares, et al.
Science Translational Medicine|October 24, 2014
Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomographyEdward A Weinstein, Alvaro A Ordonez, Vincent P DeMarco, et al.
Pageof 53

Showing results (331-340 of 525) with videos related to

Sort By:
Pageof 53
European Journal of Nuclear Medicine and Molecular Imaging|August 14, 2022
Hetero-bivalent agents targeting FAP and PSMASrikanth Boinapally, Alla Lisok, Gabriela Lofland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2023
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial CarcinomaXiaojiang Duan, Lei Xia, Zhuochen Zhang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2000
Radiolabeled neuronal nitric oxide synthase inhibitors: synthesis, in vivo evaluation, and primate PET studiesM G Pomper, J L Musachio, U Scheffel, et al.
European Journal of Radiology|September 3, 2013
Detection and localization of carcinoma within the prostate using high resolution transrectal gamma imaging (TRGI) of monoclonal antibody directed at prostate specific membrane antigen (PSMA)--proof of concept and initial imaging resultsBenjamin L Franc, Steve Y Cho, Seth A Rosenthal, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Molecular Imaging in Multiple Myeloma-Novel PET Radiotracers Improve Patient Management and Guide TherapyJohannes von Hinten, Malte Kircher, Alexander Dierks, et al.
Cancers|February 15, 2022
Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [<sup>177</sup>Lu]Lu-PSMA I&TPhilipp E Hartrampf, Franz-Xaver Weinzierl, Sebastian E Serfling, et al.
Frontiers in Oncology|December 2, 2022
Automated lesion detection of breast cancer in [<sup>18</sup>F] FDG PET/CT using a novel AI-Based workflowJeffrey P Leal, Steven P Rowe, Vered Stearns, et al.
Journal of Medicinal Chemistry|December 5, 2008
Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancerYing Chen, Catherine A Foss, Youngjoo Byun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Real-time, near-infrared fluorescence imaging with an optimized dye/light source/camera combination for surgical guidance of prostate cancerBrian P Neuman, John B Eifler, Mark Castanares, et al.
Science Translational Medicine|October 24, 2014
Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomographyEdward A Weinstein, Alvaro A Ordonez, Vincent P DeMarco, et al.
Pageof 53